Rhode Island HB 5323: AN ACT RELATING TO BUSINESSES AND PROFESSIONS - PHARMACEUTICAL COST TRANSPARENCY (Directs the state board of pharmacy, in collaboration with the Rhode Island department of health, to annually identify up to fifteen (15) prescription drugs on which the state spends significant health care dollars due to increases in costs.)

Status: 02/14/2017 Committee recommended measure be held for further study (as of 2017-02-14)

State: Rhode Island · Session: 2017 · Bill: HB 5323

Subjects: Prescription drugs, Health & Safety

Sponsors: Hull, Lombardi, McKiernan, Messier, Morin

View Rhode Island HB 5323 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.